The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Regulatory Affairs Compliance Strategies
Read More
post
The FDA NDA Review Timeline Explained: A Step-by-Step Breakdown
Read More
post
Project Orbis: Accelerating Global Access to Innovative Cancer Therapies
Read More
post
The Importance of Quality in Drug Development with Insights from the FDA Fiscal Year 2023 Report on the State of Pharmaceutical Quality
Read More
Let's move from science to success.
Let’s Talk